Head-To-Head Analysis: Integra LifeSciences (NASDAQ:IART) & Titan Medical (NASDAQ:TMDIF)

Integra LifeSciences (NASDAQ:IART) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Integra LifeSciences and Titan Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	3	4	1	0	1.75
Titan Medical	0	0	0	0	0.00

Integra LifeSciences presently has a consensus target price of $23.00, suggesting a potential upside of 3.93%. Given Integra LifeSciences’ stronger consensus rating and higher probable upside, equities analysts clearly believe Integra LifeSciences is more favorable than Titan Medical.

Profitability

This table compares Integra LifeSciences and Titan Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-0.42%	12.35%	4.82%
Titan Medical	N/A	-82.31%	-51.47%

Risk & Volatility

Integra LifeSciences has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500.

Institutional & Insider Ownership

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 3.1% of Integra LifeSciences shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Integra LifeSciences and Titan Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.56 billion	1.09	$67.74 million	($0.09)	-245.89
Titan Medical	$17.63 million	2.59	$6.95 million	$0.05	8.00

Integra LifeSciences has higher revenue and earnings than Titan Medical. Integra LifeSciences is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Integra LifeSciences beats Titan Medical on 9 of the 14 factors compared between the two stocks.

About Integra LifeSciences

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

About Titan Medical

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.